Bi-Wen Yeh
Overview
Explore the profile of Bi-Wen Yeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan T, Pan C, Hsieh H, Vejvisithsakul P, Wei R, Yeh B, et al.
Cell Oncol (Dordr)
. 2024 Oct;
47(6):2461-2462.
PMID: 39419942
No abstract available.
2.
Chien T, Yang C, Yen C, Yeh B, Wu W, Sheu J, et al.
Arch Toxicol
. 2024 Feb;
98(5):1543-1560.
PMID: 38424264
Excavatolide C (EXCC), a marine coral-derived compound, exhibits an antiproliferation effect on bladder cancer cells. The present study evaluated the improvement in the antiproliferation ability of EXCC by co-treatment with...
3.
Chan T, Pan C, Hsieh H, Vejvisithsakul P, Wei R, Yeh B, et al.
Cell Oncol (Dordr)
. 2023 Mar;
46(4):933-951.
PMID: 36920729
Purpose: Urothelial carcinoma (UC) is a common disease in developed counties. This study aimed to identify autocrine roles and signaling pathways of gremlin 1, DAN family BMP antagonist (GREM1), which...
4.
Chien T, Wu K, Chuang Y, Yeh Y, Wang H, Yeh B, et al.
Antioxidants (Basel)
. 2021 Jul;
10(7).
PMID: 34209212
Withaferin A (WFA), the Indian ginseng bioactive compound, exhibits an antiproliferation effect on several kinds of cancer, but it was rarely reported in bladder cancer cells. This study aims to...
5.
Yeh B, Yu L, Li C, Yang J, Li W, Wu Y, et al.
Toxicol Appl Pharmacol
. 2020 Jul;
402:115129.
PMID: 32673656
Urothelial carcinoma (UC) is one of the highest incidence cancers that rank the fourth commonly diagnosed tumors worldwide. The unresectable lesions that are resistant to therapeutic interventions is the major...
6.
Yeh H, Li C, Wen S, Singla N, Woldu S, Robyak H, et al.
J Clin Med
. 2020 Apr;
9(4).
PMID: 32340364
Hyponatremia has been shown to be associated with prognosis in various cancers, but its role in upper tract urothelial carcinoma (UTUC) is largely unidentified. We created an international multiregional cohort...
7.
Yeh H, Li C, Chien T, Li C, Cheng Y, Woldu S, et al.
World J Urol
. 2020 Apr;
39(2):491-500.
PMID: 32318857
Purpose: Inconsistent prognostic implications of body mass index (BMI) in upper tract urothelial carcinoma (UTUC) have been reported across different ethnicities. In this study, we aimed to analyze the oncologic...
8.
Chien T, Chan T, Huang S, Yeh B, Li W, Huang C, et al.
Cancers (Basel)
. 2020 Mar;
12(3).
PMID: 32182788
We sought to examine the relationship between microtubule-associated proteins (MAPs) and the prognosis of urothelial carcinoma by assessing the microtubule bundle formation genes using a reappraisal transcriptome dataset of urothelial...
9.
Wu W, Lin J, Pan C, Chan T, Liu C, Wu W, et al.
Theranostics
. 2020 Jan;
10(2):707-724.
PMID: 31903146
Muscle-invasive urinary bladder urothelial carcinoma (UBUC) is a lethal disease for which effective prognostic markers and potential therapy targets are still lacking. Previous array comparative genomic hybridization identified that 3q27...
10.
Kuo M, Chang W, Yeh B, Chu Y, Lee Y, Lee H
Cells
. 2019 Dec;
8(12).
PMID: 31817208
Breast cancer brain metastasis commonly occurs in one-fourth of breast cancer patients and is associated with poor prognosis. Abnormal glucose metabolism is found to promote cancer metastasis. Moreover, the tumor...